Nabavi, S.M.; Mehrabani, M.; Ghalichi, L.; Nahayati, M.A.; Ghaffari, M.; Ashtari, F.; Mohammadianinejad, S.E.; Karimi, S.; Faghani, L.; Yazdanbakhsh, S.;
et al. COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran. Vaccines 2022, 10, 135.
https://doi.org/10.3390/vaccines10010135
AMA Style
Nabavi SM, Mehrabani M, Ghalichi L, Nahayati MA, Ghaffari M, Ashtari F, Mohammadianinejad SE, Karimi S, Faghani L, Yazdanbakhsh S,
et al. COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran. Vaccines. 2022; 10(1):135.
https://doi.org/10.3390/vaccines10010135
Chicago/Turabian Style
Nabavi, Seyed Massood, Mehrnoosh Mehrabani, Leila Ghalichi, Mohammad Ali Nahayati, Mehran Ghaffari, Fereshteh Ashtari, Seyed Ehsan Mohammadianinejad, Shahedeh Karimi, Leila Faghani, Sepideh Yazdanbakhsh,
and et al. 2022. "COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran" Vaccines 10, no. 1: 135.
https://doi.org/10.3390/vaccines10010135
APA Style
Nabavi, S. M., Mehrabani, M., Ghalichi, L., Nahayati, M. A., Ghaffari, M., Ashtari, F., Mohammadianinejad, S. E., Karimi, S., Faghani, L., Yazdanbakhsh, S., Najafian, A., Shahpasand, K., & Vosough, M.
(2022). COVID-19 Vaccination Willingness and Acceptability in Multiple Sclerosis Patients: A Cross Sectional Study in Iran. Vaccines, 10(1), 135.
https://doi.org/10.3390/vaccines10010135
